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Abstract This study aimed to determine whether partic-
ipants reported altering health behaviors (physical activity,
diet, and alcohol consumption) after seeing results from an
electron-beam computed tomography (EBCT) scan for
coronary artery calcium and reviewing these results with
a physician. Clinicians attempt to motivate patients to
control cardiovascular risk factors by adopting healthy
behaviors and reducing harmful actions. Asymptomatic
patients (N = 510) were evaluated by EBCT for the extent
of coronary artery calcium. Information pertaining to
demographics, health history, and lifestyle/health behaviors
was obtained from each participant at the time of the EBCT
scan. Patients were given their numerical calcium score,
shown images of their coronary arteries, and counseled by
a physician for lifestyle and medical risk modiﬁcation
based on their coronary artery calcium score. Approxi-
mately 6 years after the scan, participants completed a
follow-up questionnaire related to lifestyle modiﬁcations.
In multivariable analysis, the presence and extent of cor-
onary artery calcium was signiﬁcantly associated with
beneﬁcial health behavior modiﬁcations. Speciﬁcally, the
greater a patient’s coronary artery calcium score, the
more likely they were to report increasing exercise (odds
ratio = 1.34, P = 0.02), changing diet (odds ratio = 1.40,
P\0.01), and changing alcohol intake (odds ratio = 1.46,
P = 0.05). This study suggests that seeing and being
counseled on the presence and extent of coronary artery
calcium is signiﬁcantly associated with behavior change.
Keywords Health behavior  Physical activity 
Nutrition  Coronary artery calcium  Imaging
Introduction
Altering lifestyle patterns to reduce risk for cardiovascular
disease is a challenging yet potentially rewarding strategy.
The INTERHEART study demonstrated that optimizing
nine modiﬁable risk factors could reduce risk for a ﬁrst heart
attack by over 90% (Yusuf et al. 2004). Recent data shows
thatonly15%ofAmericansoverage18engagein30 minof
moderate activity ﬁve or more days per week (Klein et al.
2002). However, 65% of Americans are overweight or ob-
ese, while only 11% of Americans meet the USDA guide-
lines for fruit and vegetable intake (Klein et al. 2002).
Coronary artery calcium (CAC) as measured by com-
puted tomography (CT) scanning of the heart is an accurate
measure of coronary atherosclerosis. Moreover, the 2009
American Heart Association Heart Disease and Stroke Sta-
tistics 2009 Update states ‘‘CAC is a measure of the burden
of atherosclerosis in the heart arteries.’’ The Update also
cites data from the NHLBI-sponsored Multiethnic Study of
Atherosclerosis (MESA): ‘‘those with CAC scores greater
than 100 were 7–10 times more likely to experience a cor-
onary event than those without CAC’’ (Detrano et al. 2008).
A handful of studies have examined the effects of CT
scanning on behavior change. For example, LaBounty et al.
(2009) showed that greater severity of coronary artery
disease (CAD), as revealed via coronary computed tomo-
graphic angiography, was signiﬁcantly correlated with
enhanced control of CAD risk factors such as dyslipidemia
and hypertension among 208 patients with symptoms
suggestive of angina but free of established CAD. An
earlier study, reported by Wong et al. (1996), found that
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report losing weight, decreasing dietary fat, increasing
vitamin E intake, and beginning use of aspirin, cholesterol–
lowering therapy, and blood pressure medication 1 year
after receiving EBCT scan results. A third study, by
Orakzai et al. (2008), showed that patients with higher
calcium scores were more likely to initiate beneﬁcial die-
tary changes, exercise, and increased aspirin use. In a
fourth study, Kalia et al. (2006) showed that visualization
of coronary calcium on EBCT scans was associated with
increased adherence to and utilization of statin therapy.
Similarly, in the 6-year follow-up of the Prospective Army
Coronary Calcium (PACC) Project, Taylor et al. (2008)
showed that statin and aspirin use was signiﬁcantly greater
among participants with coronary calciﬁcation.
In this paper, we present data obtained at a University-
afﬁliated disease prevention clinic. Patients underwent
CAC scoring and Framingham risk assessment followed by
a 15–30 min consultation with a physician to review the
results and receive both lifestyle and medication recom-
mendations. Approximately 6 years later, the patients were
queried to determine if seeing the CAC scan results, along
with the physician counseling, was associated with risk-
reducing behavioral changes.
Materials and methods
Subjects
Chest EBCT scans were performed on asymptomatic
patients from October 1999 to May 2002 at a university-
afﬁliated disease prevention center in San Diego, CA to
examine the extent of atherosclerotic calciﬁcation in the
coronary arteries. This clinical population of participants
was either physician or self-referred as a supplement to
their preventive health care. Prior studies based on data
from this cohort have been published (Allison et al. 2004,
2006, 2007). Patients with known coronary heart disease or
who had a history of coronary heart disease related surgery
were excluded from the study.
EBCT scans were performed at the ﬁrst clinic visit
(baseline), and all participants completed a detailed health
history questionnaire that collected information on demo-
graphics, diabetes, hypertension, smoking, alcohol con-
sumption, diet, exercise, and family history of coronary
heart disease at that time. Blood pressure was obtained by
automated oscillometry after the patient rested for 5 min in
a seated position. Body mass index (BMI), body fat per-
centage, total cholesterol, high density lipoproteins (HDL),
low density lipoproteins, triglycerides (serum cholesterol
indices), and glucose were also measured during this
baseline clinic visit.
Laboratory
All patients underwent serum lipid analysis using the
CholestechLDXsystem(Cholestech,Hayward,California).
Blood specimens were obtained by ﬁngerstick with the
subject in the seated position using a 35 ll lithium heparin-
coated capillary tube. BMI was calculated with the patient
clothed but shoe-less and expressed in kg/m
2. Body fat was
measuredusingbioimpedence on the Omron HBF-300 body
fat analyzer (Omron, Schaumburg, Illinois).
Imaging
An Imatron C-150 (General Electric, San Francisco,
California) was utilized to perform a single scan to obtain
images of each patient’s heart. The 100-ms scan time
proceeded down from the level of the carina to the level of
the diaphragm. Approximately 40–45 contiguous slices of
each participant’s heart were obtained, each of which were
3 mm thick. Cardiac tomographic imaging was electro-
cardiographically triggered at 40 or 65% of the R–R
interval, depending on the patient’s heart rate. Imaging of
the heart was conducted during one breath hold at one-half-
maximal inspiration. The coronary vascular bed consisted
of the left circumﬂex, left anterior descending, left main
and right coronary arteries.
Coronary calciﬁcation was deﬁned as a plaque area =
1.00 mm
2 (C3 pixels) with a density of C130 Hounsﬁeld
units (HU). Quantitative measures of calcium scores were
determined according to the technique explained by
Agatston et al. (1990); this calcium scoring was performed
by either a computed tomography technician or physician
trained in the methodology outlined above. This method
has been previously described in detail (Allison et al.
2007).
Physician consultation
The patients spent approximately 15–30 min with a phy-
sician who reviewed the results of the EBCT scan, showed
the patient his/her EBCT images, discussed the risk factors
associated with CAC, and made recommendations for risk
reduction based on the patient’s CAC score. Patients were
made aware that CAC identiﬁes underlying coronary ath-
erosclerosis and is associated with incident heart disease.
The recommendations for risk reduction included nutri-
tional advice, exercise suggestions, and smoking cessation
recommendations (if pertinent).
Behavioral assessment
An average of 6 ± 1 years (range 3–9 years) after the
baseline clinic visit, patients completed a mailed follow-up
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123survey that inquired about health behavior changes after
the EBCT scan and physician consultation. Speciﬁc ques-
tions posed included whether, since the coronary artery
scan and physician consultation, the patient had decreased
or stopped smoking cigarettes if they had been smoking
at the time of the scan, started exercising, increased the
amount of exercise, changed the type of exercise they used
to perform, changed their dietary habits, or changed their
use of alcohol. The University of California at San Diego’s
Human Research Protection Program approved the study
protocol, and the requirement for informed consent was
waived by this group.
Statistical analysis
Hypertension was deﬁned either by self-report of physi-
cian-diagnosed hypertension and current use of a pre-
scription antihypertensive, or as a diastolic blood pressure
or systolic blood pressure C90 or C140 mm Hg, respec-
tively (Allison et al. 2007). Diabetes was deﬁned either by
self-report of physician-diagnosed diabetes and current use
of antiglycemic medication, or a blood glucose[200 mg/dl
(‘‘Diagnosis and classiﬁcation of diabetes mellitus’’, 2009).
Dyslipidemia was deﬁned either by total cholesterol to
HDL ratio [5, or by self-report of current use of pre-
scription cholesterol lowering medications (Natarajan et al.
2003). Participants were grouped into either never, former,
or current smokers.
The outcome variables for this study were 5 different
health behavior changes potentially made after receiving
EBCT scan results and the physician consultation: start
exercising, change diet, increase exercise, change type of
exercise, and change alcohol intake. The primary predictor
variables were presence and extent of CAC, with covariates
of age, gender, premature sibling and parent heart disease,
hypertension, dyslipidemia, BMI, diabetes, and ethnicity.
The extent of CAC, age, and BMI were analyzed as con-
tinuous variables, and presented as mean values ±SD; the
remaining variables were dichotomized and presented as
numbers (percent).
The CAC scores were both log transformed in order to
normalize the distribution of this variable, and dichoto-
mized (i.e. presence versus absence of calciﬁcation) for use
in logistic regression. Several one-way between-groups
analyses of covariance (ANCOVA) were conducted, ad-
justed for age and gender, to investigate multivariable
associations between the primary predictor variables and
outcome variables. Established risk factors for prevalent
calciﬁcation that are associated with the outcome variables
were included in Model 2 described below.
The potential impact of the presence and extent of CAC
on the likelihood that participants would report changes in
lifestyle behaviors was explored with two binary logistic
regression models. These models were ﬁrst adjusted for
only age and gender (Model 1). Next, the models were
additionally adjusted for accepted CVD risk factors and
covariates found to be signiﬁcant (P B 0.15) by the
ANCOVA analysis (Model 2). In these analyses, potential
covariates included age, gender, BMI, hypertension, dysl-
ipidemia, diabetes, and parent and sibling history of
premature heart disease. The Hosmer–Lemeshow good-
ness-of-ﬁt test was utilized to assess the logistic regression
models. This study speciﬁed a signiﬁcance level of 0.05 or
below (2-tailed) in the multivariable models. All statistical
analyses were conducted using SPSS version 16.0 statisti-
cal package.
Results
After excluding those individuals who had a history of
coronary procedure, 510 participants returned the mailed
questionnaire. Characteristics of this sample are presented
in Table 1. Patients were an average of 64 years old (SD
9.69; range 38–94) and women comprised 38.2% of the
cohort. The average BMI in this population was 26.6 (SD
4.08; range 18–41), and 41.8% were considered overweight
based on BMI. Among these patients, 21.4% had a parent
with a history of premature heart disease; 2.8% had dia-
betes; 43.9% had hypertension; 35.1% had dyslipidemia;
45.3% had smoked at some point; 4.1% were smoking at
the time of the scan; and 80.8% drank alcohol before the
scan. Two-hundred and ninety-ﬁve participants (58%) were
found to have CAC. The mean and median coronary cal-
cium scores were 202.8 and 8.5, respectively (range
0–5,117). The average duration between the baseline clinic
visit and completion of the survey was 6 ± 1 years (range
3–10).
Subsequent to receiving results of the EBCT scan and
physician consultation, 9.6% of patients reported that they
started exercising; 15.9% said they increased amount of
exercise; 11.0% said they changed the type of exercise they
were performing; 27.3% said they changed their dietary
habits; 6.3% reported that they changed their use of alco-
hol; and of the 21 (4.12%) participants who reported
smoking at the time of the scan, 3 (14.29% of those
smokers) reported decreasing or stopping smoking. Among
the 32 patients who reported a change in their use of
alcohol, 28.1% (N = 9) reported an increase in consump-
tion; 43.8% (N = 14) said they decreased consumption;
and 62.5% (N = 20) reported an increase in red wine
consumption.
The characteristics of the cohort stratiﬁed by the pres-
ence or absence of CAC are provided in Table 2. Those
with any CAC were signiﬁcantly older (66.7 vs. 61.5,
P\0.01), with a signiﬁcantly higher proportion of men
150 J Behav Med (2011) 34:148–155
123Table 1 Descriptive Statistics Characteristics Mean (continuous) or percent (categorical)
Age (years), mean (SD) (At Cycle I Questionnaire) 64.48 (10.47)
Female, n (%) 195 (38.20%)
Ethnicity, n (%)
American Indian/Alaska Native 2 (.397%)
Asian 7 (1.39%)
Black/African American 1 (.198%)
Native Hawaiian/Paciﬁc Islander 0 (0%)
White 488 (95.7%)
Other 6 (1.19%)
BMI (kg/m
2), mean 26.61 (SD = 4.084; Range = 18–41)
Parent heart disease before 55, n (%) 108 (21.4%)
Sibling heart disease before 55, n (%) 43 (8.4%)
Coronary artery calcium, mean 202.84 (SD = 523.772; Range = 0–5,117;
Median = 8.51)
Have calcium in heart (CAC[0), n (%) 295 (57.8%)
Diabetes, n (%) 14 (2.8%)
Hypertension, n (%) 224 (43.9%)
Dyslipidemia, n (%) 179 (35.1%)
Ever smoker, n (%) 231 (45.30%)
Smoked at time of scan, n (%) 21 (4.12%)
Decrease/stop smoking b/c of scan, n (%) 3 (2.36%)
Drank alcohol B4 scan, n (%) 412 (80.8%)
Changed alcohol use b/c of scan results, n (%) 32 (6.3%)
Increased consumption 9 (28.1%)
Decreased consumption 14 (43.8%)
Increased red wine consumption 20 (62.5%)
Changed diet after scan, n (%) 139 (27.3%)
Started exercising after scan, n (%) 49 (9.6%)
Increased exercise after scan, n (%) 81 (15.9%)
Changed type of exercise after scan, n (%) 56 (11.0%)
Table 2 Cohort Characteristics
Stratiﬁed by the Presence/
Absence of Coronary Artery
Calcium (ANCOVA)
BMI body mass index, CAC
coronary artery calcium
a Adjusted for gender
b Adjusted for age
c Adjusted for age and gender
Variable CAC[0( N= 295) CAC = 0( N= 215) P value
Age (years), mean (SD)
a 66.69 (10.18) 61.48 (11.07) \0.01
Female, n (%)
b 85 (29%) 110 (51%) \0.01
BMI (kg/m
2), mean (SD)
c 26.70 (3.831) 26.49 (4.412) 0.511
Parent heart disease before 55, n (%)
c 65 (22%) 44 (20%) 0.106
Sibling heart disease before 55, n (%)
c 28 (9%) 15 (7%) 0.172
Coronary artery calcium, mean
c 350.67 (SD = 650.34;
Median = 94.63)
0 (SD = 0;
Median = 0)
\.01
Diabetic, n (%)
c 13 (5.1%) 1 (0.5%) 0.016
Hypertension, n (%)
c 155 (37.36%) 69 (20.71%) \0.01
Dyslipidemia, n (%)
c 114 (38.64%) 65 (30.23%) 0.180
Smoke at time of scan
c 12 (9%) 9 (10%) 0.671
Drank alcohol before scan
c 236 (81%) 176 (83%) 0.312
Changed alcohol use after scan
c 24(8%) 8(4%) \0.01
Started exercising after scan
c 35 (12%) 14 (7%) 0.04
Increased exercise after scan
c 55 (19%) 26 (12%) \0.01
Changed exercise type after scan
c 36 (13%) 20 (10%) 0.164
Changed diet after scan
c 95 (33%) 44 (21%) \0.01
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123(71.0 vs. 29.0%, P\0.01). After adjusting for age and
gender, participants with a CAC score [0 had a signiﬁ-
cantly higher prevalence of hypertension (37.4 vs. 20.7%,
P\0.01) and diabetes (5.1% vs. 0.5%, P = 0.02), and
were more likely to change alcohol intake (8.0 vs. 4.0%,
P\0.01), start exercising (12.0 vs. 7.0%, P = 0.04), in-
crease their exercise (19.0 vs. 12.0%, P\0.01), and
change their diet (33.0 vs. 21.0%, P\0.01). Figure 1
shows the percentage of patients who changed these health
behaviors according to presence or absence of CAC, and
Fig. 2 illustrates the median CAC score by health behavior.
When controlling only for age and gender (Model 1), the
odds of participants reporting that they started exercising,
changed their diet, increased their exercise, changed type
of exercise, and changed their alcohol consumption after
the scan and physician consultation were 2.04 (P = 0.04),
1.99 (P\0.01), 2.15 (P\0.01), 1.53 (P = 0.17), and
3.00 (P = 0.02) times higher, respectively, for those with
any CAC compared to those without CAC. Using a 1-unit
increment in the log transformed CAC score, and with
adjustment for age and gender (Model 1), the odds of
participants reporting that they started exercising, changed
their diet, increased their exercise, changed type of
exercise, and changed their use of alcohol after the scan
and physician consultation were 1.43 (P = 0.01), 1.39
(P\0.01), 1.43 (P\0.01), 1.24 (P = 0.11), and 1.36
(P = 0.07) times higher, respectively.
Results from the separate ANCOVAs, which were
adjusted for age and gender, are shown in Table 3. These
results along with the results from the ANCOVAs per-
formed with the cohort stratiﬁed by the presence or absence
of CAC, determined which covariates were included in
Model 2. When all signiﬁcant covariates (P B 0.15) were
controlled for (Model 2), the odds of participants reporting
that they started exercising, changed their diet, increased
their exercise, changed type of exercise, and changed their
alcohol consumption after the scan and physician consul-
tation were 1.52 (P = 0.26), 1.74 (P = 0.02), 1.78
(P = 0.06), 1.27 (P = 0.48), 3.05 (P = 0.03) times higher,
respectively, for those with any CAC compared to those
without CAC. In this same model, but using a 1-unit
increment in the log transformed CAC score, the odds of
participants reporting that they started exercising, changed
their diet, increased their exercise, changed type of exer-
cise, and changed their use of alcohol after the scan
and physician consultation were 1.26 (P = 0.13), 1.40
(P\0.01), 1.35 (P = 0.02), 1.21 (P = 0.19), and 1.46
(P = 0.05) times higher, respectively. These odds ratios
are shown in Table 4.
Discussion
In this longitudinal study of 510 asymptomatic men and
women, the effects of EBCT scan visualization, knowledge
of CAC measurement, and brief physician consultation
were signiﬁcantly associated with changes in health related
behaviors. Speciﬁcally, patients with EBCT scans that re-
vealed CAC were more likely to begin exercising, increase
their exercise, change their diet, and change their alcohol
consumption.
Perhaps patients’ perceived threat of atherosclerotic
disease was altered after visualizing the EBCT scan and
obtaining results and a greater understanding of the dis-
ease; the ‘‘teachable moment’’ that occurs during visuali-
zation of coronary plaque burden on the EBCT scan may
be responsible for beneﬁcial lifestyle changes. The moti-
vation may be due to a change in patients’ perception of
health status or disease threat, as has been reported in
previous studies (Kalia et al. 2006; Wong et al. 1996).
Motivation for adopting healthy behaviors and modify-
ing harmful cardiovascular risk factors is multifactorial and
differs for each individual. Many models of health behavior
change integrate perceived vulnerability as a catalyst for
health-related behavior change. There are numerous mod-
iﬁable risk factors for atherosclerosis including physical
Fig. 1 Percentage of patients who changed health behaviours,
according to presence or absence of CAC
Fig. 2 Median coronary artery calcium score by health behaviour
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123inactivity, cigarette smoking, excessive alcohol consump-
tion, high-saturated fat diets, obesity, diabetes, and hyper-
tension (Allison et al. 2007; Allison and Wright 2005;
Third Report of the National Cholesterol Education Pro-
gram (NCEP) Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) ﬁnal report 2002). Several health
behaviors and lifestyle factors such as exercise, dietary
intake, smoking, and alcohol consumption are associated
with the above mentioned modiﬁable risk factors. In fact,
low-fat vegetarian diets have been shown in several studies
to signiﬁcantly reduce or have a reversal effect on coronary
atherosclerosis development (Barnard et al. 2009; Essels-
tyn 1999; Ornish et al. 1998). Showing patients their EBCT
CAC results was an apparently successful motivating
factor.
The current study lends further support for the ﬁve
previously mentioned studies showing either increased
medication compliance or beneﬁcial behavioral change
following coronary calcium screening (Kalia et al. 2006;
Orakzai et al. 2008; Wong et al. 1996; LaBounty et al.
2009; Taylor et al. 2008). Yet it contradicts the few studies
that have not shown healthy behavior changes following
CT scans for CAC screening (O’Malley et al. 2003). For
example, O’Malley et al. (2003) found that CAC screening
and knowledge of electron beam tomography results did
not signiﬁcantly motivate patients to change modiﬁable
cardiovascular disease risk factors. However, this study had
Table 3 Results from separate analyses of covariance (ANCOVA) examining multiple characteristics as indicators of probability for health
behavior change at follow-up (n = 510)
Characteristics Started exercising Increased exercise Changed exercise type
Yes
(N = 49)
No
(N = 447)
P value Yes
(N = 81)
No
(N = 416)
P value Yes
(N = 56)
No
(N = 437)
P value
Age (years), mean (SD)
a 64.71
(10.84)
64.36
(10.92)
0.15 61.41
(11.30)
64.85
(10.69)
0.41 62.66
(12.79)
64.55
(10.66)
0.20
Female, n (%)
b 20 (40.82) 169 (37.81) 0.67 33 (40.74) 157 (37.74) 0.75 21 (37.0) 168 (38.0) 0.82
BMI (kg/m
2), mean
c 27.57 26.51 0.29 26.80 26.61 0.13 26.41 26.68 0.62
Parent heart disease
before age 55, n (%)
c
11 (22.49) 91 (20.36) 0.749 18 (22.22) 87 (21) 0.97 8 (14) 93 (21) 0.18
Sibling heart disease
before age 55, n (%)
c
8 (16.33) 34 (7.61) 0.04 10 (12.0) 32 (8.0) 0.18 5 (9.0) 36 (8.0) 0.87
Coronary artery calcium,
mean (SD)
c
338.90
(823.97)
190.43
(485.23)
\0.01 316.07
(785.0)
177.82
(457.0)
\0.01 390.26
(921)
177.03
(445)
0.23
CAC[0, n (%)
c 35 (71.43) 255 (57.05) 0.04 55 (67.90) 232 (55.77) \0.01 36 (64.29) 248 (56.75) 0.16
Diabetes, n (%)
c 3 (6.7) 11 (2.8) 0.17 3 (4.0) 11 (3.0) 0.595 0 (0) 14 (3.6) 0.20
Hypertension, n (%)
c 34 (69.39) 182 (40.72) \0.01 39 (48.15) 178 (42.79) 0.13 28 (50.0) 186 (42.56) 0.18
Dyslipidemia, n (%)
c 25 (51.02) 150 (33.56) 0.01 46 (56.79) 130 (31.25) \0.01 28 (50.0) 146 (33.41) 0.01
Characteristics Changed diet Changed alcohol
Yes (N = 141) No (N = 357) P value Yes (N = 32) No (N = 462) P value
Age (years), mean (SD)
a 63.38 (11.95) 64.67 (10.46) 0.856 57.88 (18.55) 64.84 (10.01) \0.01
Female, n (%)
b 48 (34.53) 139 (38.72) 0.33 7 (22.0) 181 (39.0) 0.03
BMI (kg/m
2), mean
c 26.79 26.56 0.15 27.35 26.58 0.41
Parent heart disease before age 55, n (%)
c 29 (21) 75 (21) 0.97 2 (6.0) 102 (22.0) 0.02
Sibling heart disease before age 55, n (%)
c 12 (8.63) 31 (8.64) 0.99 5 (12.0) 37 (8.0) 0.14
Coronary artery calcium, mean (SD)
c 284.12 (655.35) 177.40 (469.14) 0.03 334.05 (610) 183.51 (501) 0.04
CAC[0, n (%)
c 95 (68.35) 195 (54.32) \0.01 24 (75.0) 260 (56.28) \0.01
Diabetes, n (%)
c 6 (4.8) 7 (2.2) 0.18 0 (0) 14 (3.4) 0.32
Hypertension, n (%)
c 65 (46.76) 154 (42.90) 0.32 14 (43.75) 201 (43.51) 0.50
Dyslipidemia, n (%)
c 61 (43.88) 113 (31.48) 0.01 15 (46.88) 159 (34.42) 0.27
BMI body mass index, CAC coronary artery calcium
a Adjusted for gender
b Adjusted for age
c Adjusted for age and gender
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123several limitations, such as a low prevalence of modiﬁable
risk factors and coronary calciﬁcation among participants,
which may have insufﬁciently demonstrated behavior
change since disease is presumably the motivating factor
(O’Malley et al. 2003). The ﬁrst study to investigate the
effects of CAC screening via EBCT on cardiovascular risk-
reducing behaviors found increases in several of these
behaviors to be associated with the amount of CAC, but
CAC was not related to changes in physical activity or
tobacco use (Wong et al. 1996). Also, in a study involving
144 asymptomatic smokers self-referred for EBCT, there
was no relationship between the presence of CAC and
smoking behavior changes or cessation (O’Malley et al.
2002). It is important to note that the patients in the current
study received only a brief physician consultation for
behavior modiﬁcation. Longer and more structured advice
may have had a greater effect on health behavior change.
Study limitations
This study has several limitations. First, generalizability of
results may be limited due to the self-referred patients, who
may not comprise a representative sample of the population.
These patients are likely to be more conscious of health
related matters and from higher socioeconomic status, thus
perhaps engaging in more routine health prevention and
improvement than the general population. Also, these
patients were predominantly Caucasian, which may hinder
applicability of the results to other populations. Second,
these participants were free of clinical cardiovascular dis-
ease. These issues could have led to an underestimation of
the affects of established cardiovascular risk factors on
CAC. Third, this study lacked a true control group, and was
observational in nature. Fourth, self-reported behavior
changes were subjective, non-quantitative, and speciﬁcs
pertaining to changes and increases in exercise duration
were not reported, thereby perhaps limiting the ability to
precisely quantify effects. Research has shown that self-
report of prescription compliance and involvement in
healthy behaviors tends to be overestimated, and often
suffers from recall bias (Liu et al. 2001; Straka et al. 1997).
Fifth, it is unknown how long health behavior changes are
sustained following screening for cardiovascular disease
risk factors, but some evidence shows these changes
diminish over time. Because there was an average of
6 years between baseline EBCT scan and the follow-up
survey, many patients may have initially adopted beneﬁcial
lifestyle behaviors, but after 6 years these behaviors may
have ceased, thereby underestimating the affects of EBCT
scan results on motivation. Finally, we carefully controlled
for confounders that could have inﬂuenced behavior change
and risk for cardiovascular disease,but it was not possible to
control for all potential confounders, such as patients’
motivation.
Conclusion
In summary, this study suggests that EBCT coronary cal-
cium screening may be signiﬁcant and useful not only in
diagnosing coronary atherosclerosis, but also in motivating
beneﬁcial lifestyle behaviors in asymptomatic patients.
Hopefully these results will encourage the performance of
Table 4 Binary logistic regression models (Odds ratios (95% conﬁdence intervals); P-values)
Variables Started exercising Increased exercise Changed exercise type
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
CAC (Yes/No) 2.04 (1.03,4.02);
P = .04
1.52 (.73,3.16);
P = .26
2.15 (1.25,3.69);
P\.01
1.78 (.99,3.20);
P = .055
1.53 (.83,2.80);
P = .17
1.27(.65,2.48);
P = .48
CAC (Continuous -log
transformed)
1.43 (1.08,1.89);
P = .01
1.26 (.93,1.72);
P = .13
1.43 (1.13,1.80);
P\.01
1.35 (1.05,1.74);
P = .02
1.24 (.95,1.61);
P = .11
1.21(.91,1.62);
P = .19
Variables Changed diet Changed alcohol use
Model 1 Model 2 Model 1 Model 2
CAC (Yes/No) 1.99 (1.29,3.09);
P\.01
1.74 (1.08,2.81);
P = .02
3.00 (1.23,7.32);
P = .02
3.05(1.12,8.35);
P = .03
CAC (Continuous-log
transformed)
1.39 (1.15,1.67);
P\.01
1.40(1.13,1.73);
P\.01
1.36 (.97,1.91);
P = .07
1.46(.99,2.15);
P = .05
Model 1 = primary predictor variables + age + gender
Model 2 = Model 1 + signiﬁcant covariates [BMI, Dyslipidemia, Diabetes, Hypertension, Parent Heart Disease, Sibling Heart Disease]
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EBCT scan results or other cardiovascular screening
techniques.
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